AbCellera Biologics Inc.ABCLNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank86
3Y CAGR+81.0%
5Y CAGR-37.4%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
+81.0%/yr
Annual compound
5Y CAGR
-37.4%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
2025160.56%
2024-24.17%
2023-90.92%
202227.09%
202160.03%
20201674.13%
201931.49%
20180.00%